While immunostimulatory therapies are effective at bolstering anti-tumour effects in the setting of obesity (10, 67), it is unclear how an immunosuppressive mechanism, like PD-L1 expression by MSCs, might behave in the same environment. Here, CD274 is linked to Obesity.